Adicet Bio, Inc.
ACET · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $56 | $69 | $85 |
| - Cash | $29 | $35 | $28 | $56 |
| + Debt | $12 | $15 | $16 | $17 |
| Enterprise Value | – | $36 | $57 | $45 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$25 | -$30 | -$27 | -$27 |
| % Margin | – | – | – | – |
| Net Income | -$27 | -$31 | -$28 | -$29 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.29 | -0.34 | -0.31 | -0.32 |
| % Growth | 14.7% | -9.7% | 3.1% | – |
| Operating Cash Flow | -$22 | -$27 | -$25 | -$24 |
| Capital Expenditures | -$0 | -$0 | -$1 | -$0 |
| Free Cash Flow | -$23 | -$27 | -$27 | -$24 |